Why the study?
Diagnosis and treatment of patients with familial hypercholesterolemia are associated with certain difficulties.
This review summarizes the current understanding of familial hypercholesterolemia, including its prevalence, diagnosis, prevention of cardiovascular events, and lipid-lowering therapy.
Answers are grounded in this paper and cite their sources.
Highlights FH diagnostic challenges and CV prevention strategies; leaves open optimal population screening approaches.
Familial hypercholesterolemia is the most common hereditary disease characterized by an increase in low density lipoprotein cholesterol levels and the premature development of atherosclerosis-related cardiovascular diseases. Diagnosis and treatment of such patients are associated with certain difficulties. This review presents data on the prevalence of familial hypercholesterolemia, identification of patients with such a diagnosis, prevention of adverse cardiovascular events, and also discusses the appointment of lipid-lowering therapy.
No takes yet. Share an insight, caveat, or question.
Bliznyuk et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: